Dr. Plym[/caption]
Anna Plym PhD
Department of Medical Epidemiology and Biostatistics,
Karolinska Institutet, Stockholm, Sweden
Department of Epidemiology, Harvard T. H. Chan School of Public Health
Department of Urology, Brigham and Women’s Hospital
Harvard Medical School, Boston, Massachusetts
MedicalResearch.com: What is the background for this study?
Response: Prostate cancer is one of the leading causes of cancer death among men, with approximately one third of the deaths occurring before the age of 75 years. There is a need for a better understanding of the risk factors for those early deaths. Our previous research has indicated that inherited factors play a major role.
Prof. Abraham[/caption]
Professor Soman Abraham PhD
Grace Kerby Distinguished Professor of Pathology
Duke University.
Dr. Abraham led the research when working in the Emerging Infectious Diseases Research Programme
at Duke-NUS Medical School in Singapore
MedicalResearch.com: What is the background for this study?
Response: The degranulation of mast cells (MCs) is a process that leads to allergic symptoms, ranging from itching, redness, and swelling of the tissue to severe and potentially life-threatening anaphylaxis involving multiple organ systems. According to the World Health Organization (WHO), more than 10 per cent of the global population suffers from food allergies. As allergy rates continue to rise, so does the incidence of food-triggered anaphylaxis and asthma worldwide. In view of the fact that allergic diseases are difficult to prevent or treat, we sought to understand the underlying basis for anaphylactic reactions.
Dr. O’Sullivan[/caption]
Roderick J. O’Sullivan PhD
Associate Professor
Department of Pharmacology and Chemical Biology
UPMC Hillman Cancer Center
University of Pittsburgh
Pittsburgh, PA
MedicalResearch.com: What is the background for this study?
Response: For a few years, my group has had the good fortune of collaborating with Dr. Ivan Ahel. Ivan is a world leader in the field of ADP-ribosylation. His work has identified major gaps in our understanding of ADP-ribosylation. This includes his lab discovering that DNA bases can be ADP-ribosylated in bacteria and that a poorly characterized enzyme known as TARG1 could be involved in that process. In discussing this work with Ivan, we were confident that DNA ADP-ribosylation also exists in human cells and that showing this could be pretty important. The problem was that identifying a part of the genome where it might be present, so we could study it, was not so obvious and challenging. But we had a hunch that telomeres could be one part of the genome where it could happen!!
Telomeres are really special structures located at the ends of each human chromosome. They demarcate the physical end of each chromosome and prevent chromosomes from becoming entangled – which if it happens, is catastrophic for cells. Our hunch was based on the evidence from other studies that telomeres are natural targets of PARP1, the enzyme that catalyzes most of the ADP-ribosylation in human cells. I then discussed this idea with Anne Wondisford, a medical scientist trainee in the lab, who liked the idea and designed a series of experiments to test it.
Dr. Guasch-Ferré[/caption]
Marta Guasch-Ferré, PhD
Associate Professor and Deputy Head of Section, Section of Epidemiology
University of Copenhagen
Group Leader, Novo Nordisk Foundation Center for Basic Metabolic Research
Adjunct Associate Professor, Department of Nutrition
Harvard TH Chan School of Public Health
MedicalResearch.com: What is the background for this study?
Response: Olive oil is rich in monounsaturated fats and contains compounds with antioxidant activity that may play a protective role for the brain. Olive oil as part of a Mediterranean diet appears to have a beneficial effect against cognitive decline. Higher olive oil intake was previously associated with a lower risk of cardiovascular disease and mortality. But its association with dementia mortality was unknown.
Dr. Tsugawa[/caption]
Yusuke Tsugawa, MD, PhD
Associate Professor of Medicine & Health Policy and Management, UCLA
Director of Data Core, UCLA Department of Medicine Statistics Core
Division of General Internal Medicine and Health Services Research
David Geffen School of Medicine at UCLA
Los Angeles, CA 90024
MedicalResearch.com: What is the background for this study?
Response: Prior studies have found that female and male physicians practice medicine differently. For example, female physicians are, on average, more likely to abide by clinical guidelines and spend more time listening to patients. However, evidence was limited as to whether such differences have clinically meaningful impact on patients’ health outcomes, which was the aim of this study.
John W. Ayers, PhD MA
Vice Chief of Innovation | Assoc. ProfessorIn late 2022, X introduced Community Notes. This novel approach empowers volunteer, independent, anonymous, and ideologically diverse contributors to identify posts containing misinformation and to rectify misinformation by appending informative "notes" to suspect posts. The process is controlled by the public, instead of decision-makers at the company. Most importantly the system is open-sourced so it can be studied by external scientists.
Dr. Dekel[/caption]
Sharon Dekel PhD
Principal Investigator
Director of the Postpartum Traumatic Stress Disorders Research Program
Department of Psychiatry, Massachusetts General Hospital
Department of Psychiatry, Harvard Medical School
Boston, MA, 02114
MedicalResearch.com: What is the background for this study?
Response: Maternal psychopathologies affect a significant number of American women and are the leading complications of childbirth and a significant contributor to maternal death. Maternal (physical) morbidity in the US remain the highest among all countries in the West, suggesting that some women will have a traumatic childbirth experience.
The most common mental illness associated with trauma is posttraumatic stress disorder (PTSD). PTSD stemming from childbirth is estimated to affect 6% of delivering women (https://pubmed.ncbi.nlm.nih.gov/28443054/). In high-risk groups, for example women who have unscheduled Cesareans the rate is estimated at 20% or higher (https://pubmed.ncbi.nlm.nih.gov/31041603/.).
Although we screen for postpartum depression in hospitals in the USA there is no screening for what we define as childbirth-related PTSD (CB-PTSD). The overarching goal of the Dekel Lab is to develop novel and patient-friendly screening tools to identify women with this disorder. As importantly traumatic childbirth disproportionality affects Black and Latina women (https://pubmed.ncbi.nlm.nih.gov/35598158/).
Dr. Vazquez[/caption]
Miguel A. Vazquez, MD
Professor of Internal Medicine
University of Texas Southwestern Medical Center
MedicalResearch.com: What is the background for this study?
Response: The main reason to conduct our trial was to improve the care of patients with coexistent chronic kidney disease CKD), type 2 diabetes and hypertension. Patients with this triad are at high risk for multiple complications, end stage kidney disease and premature death. There are effective interventions for these conditions. Unfortunately, detection and awareness of CKD is low and many patients do not receive interventions that could be beneficial
In our study in patients with the coexistent triad of chronic kidney disease, type 2 diabetes, and hypertension the use of an electronic algorithm to identify patients from the electronic health record and practice facilitators embedded in four large health systems to assist primary practitioners deliver evidence-based care did not lower hospitalizations when compared to usual care.
Dr. DeCarli[/caption]
Charles DeCarli, MD, FAAN, FAHA
Victor and Genevieve Orsi Chair in Alzheimer's Research
Distinguished Professor of Neurology
Director, Alzheimer's Disease Research Center
and Imaging of Dementia and Aging (IDeA) Laboratory
Department of Neurology and Center for Neuroscience
University of California at Davis
Sacramento, CA 95817
MedicalResearch.com: What is the background for this study?
Response: The overall health of the U.S. population has improved dramatically over the last 100 years, Individuals are also living longer resulting in an increasing percentage of the population at risk for Alzheimer’s disease and related dementias (ADRD). Recent data from the Framingham Heart study, however, finds that dementia incidence may be declining. While many factors such as greater educational achievement and medical management of vascular risk factors may explain part of this effect, early life environmental differences also likely contribute.
Dr. Cortese[/caption]
Marianna Cortese, MD, PhD
Senior Research Scientist
Dr. Attur[/caption]
Mukundan G. Attur, PhD
Associate Professor, Department of Medicine
NYU Grossman School of Medicine
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The study investigates the potential protective effects of a genetic variant of IL1RN against inflammation and severe outcomes, particularly in COVID-19. Previous research indicates that carriers of this genetic variant may experience less severe radiographic knee osteoarthritis and decreased inflammation in rheumatoid arthritis patients. Given the emergence of cytokine release syndrome in COVID-19 patients, the researchers sought to understand whether the same genetic variant could offer protection against inflammation and potential death in COVID-19 cases.
Prof. Hampshire[/caption]
Prof. Adam Hampshire Ph.D.
Faculty of Medicine, Department of Brain Sciences
Professor in Restorative Neurosciences
Imperial College London
MedicalResearch.com: What is the background for this study?
Response: Cognitive symptoms after coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are well-recognized. Whether objectively measurable cognitive deficits exist and how long they persist are unclear.
Dr. Hoshi[/caption]
Rosangela Akemi Hoshi, Ph.D.
Lemann Foundation Cardiovascular Research Postdoctoral Fellowship
Center for Lipid Metabolomics
Divisions of Preventive and Cardiovascular Medicine
Brigham and Women's Hospital
Boston, MA
MedicalResearch.com: What is the background for this study? Would you describe the IgG N-glycan profile?
Response: Glycans are sugar coatings of proteins, made of monosaccharide building blocks, that are involved in a variety of biological pathways. Different sugar structures can dictate or modify the protein’s activity through specific interactions with cellular receptors. For example, proteins lacking glycans have a reduced level or a complete loss of function. Glycans are of such importance that the 2022 Nobel Prize in chemistry was awarded for glycan-based science.
In this study, we examined glycans attached to Immunoglobulins G (IgG) and their link with incidence of cardiovascular disease (CVD) due to their impact on IgG inflammatory properties. Since inflammation is not only a cause, but also an aggravating factor and a mediator of a worse prognosis in cardiometabolic disorders and CVD, we investigated whether different glycan structures may characterize an at-risk phenotype for CVD development.
Determining glycan profiles involved in multiple conditions can serve prognostic and diagnostic purposes. Yet, unlike other types of macromolecules, glycans are still not as much explored, characterizing a promising but underappreciated class that should be further investigated.
Dr. Das[/caption]
Jishnu Das, Ph.D.
Center for Systems Immunology
Departments of Immunology and Computational & Systems Biology,
Assistant Professor School of Medicine
University of Pittsburgh
MedicalResearch.com: What is the background for this study? How does this new AI model work? How is it different from other models?
Response: Modern multi-omic technologies generate an enormous amount of data across scales of organization, and with differing resolution. While recent machine learning methods have harnessed these to predict clinical/physiological outcomes, they are often black boxes that do not provide meaningful inference beyond prediction. Differences in data generation modalities, redundancy in the data, as well as large numbers of irrelevant features make inference of biological mechanisms from high-dimensional omic datasets challenging.
To address these challenges, we developed a machine learning technique called SLIDE (Significant Latent Factor Interaction Discovery and Exploration). We reasoned that features that are directly measured by current technologies are constrained by strengths and weaknesses of current platforms. So, while some observed features may be excellent correlates of outcomes of interest, inferring biological mechanisms from these multi-omic datasets requires us to delve beyond the observable into the hidden states, i.e., latent factors. These hidden states encapsulate the true drivers of underlying biological processes and capture a complex multi-scale interplay between entities measured by these datasets. Our method moves beyond simple biomarkers/correlates (“the what”) to hidden states that actually explain clinical/physiological outcomes (“the how” and “the why”).
Wilson N. Merrell
Ph.D. Student
Department of Psychology
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: From the common cold to COVID-19, people get sick all the time. Because our social worlds don’t pause just because we are feeling ill, we often still need to navigate in-person events ranging from work and school to first dates and family dinners even while we’re feeling under the weather. In these kinds of social situations, do we always tell others when we’re feeling sick, or are there times when we may want to downplay our illness? After all, we tend to react negatively to, find less attractive, and steer clear of people who are sick with infectious illness. To the extent that we want to avoid these negative social outcomes while sick, it therefore makes sense that we may take steps to cover up our sickness in social situations. Given that this concealment could serve individual social goals (like allowing you to connect with others) at the cost of broader harms to public health (through the spread of infectious disease), we found this behavior both theoretically novel and practically timely.
Dr. Zheng-Yi Chen[/caption]
Zheng-Yi Chen, D.Phil.
Department of Otolaryngology-Head and Neck Surger
Harvard Medical School
Boston, MA
MedicalResearch.com: What is the background for this study? Would you briefly explain the process and indication
Response: This clinical trial is to use gene therapy to treat a type of genetic hearing loss. Genetic hearing loss mainly affects children. One in 600 newborns can have genetic hearing loss. There is no drug treatment for any type of hearing loss except for cochlear implants, which have limitations. This study focuses on a type of genetic hearing loss, DFNB9, due to a missing gene called Otoferlin. Without Otoferlin, children are born with complete hearing loss and without the capacity to speak. The goal of the trial is to study if gene therapy is safe and efficacious in treating children so they can regain hearing and the ability to speak.
Prof. Mitragotri[/caption]
Samir Mitragotri Ph.D.
Hiller Professor of Bioengineering
Hansjorg Wyss Professor of Biologically Inspired Engineering
Area Chair, Bioengineering
Core Faculty Member, Wyss Institute for Biologically Inspired Engineering
Harvard John A. Paulson School Of Engineering And Applied Sciences
MedicalResearch.com: What is the background for this study?
Response: Traumatic brain injury (TBI) has a heavy burden on the world, affecting ~70 million people globally each year. Despite its prevalence, there are no clinically approved treatments beyond symptom management. There is an urgent need to develop effective therapies to alleviate the damage caused by TBI.
MedicalResearch.com: What do macrophages typically do?
As part of the innate immune system, macrophages migrate to areas of injury to eat pathogens or debris and manage inflammation in response to injury or infection. However, in the majority of cases of TBI, there is no actual infection from a foreign pathogen, leading to excessive inflammation that spreads damage beyond the initial impact.
Laura Gould[/caption]
Laura Gould, MSc, MA, PT
Research Scientist
SUDC Registry and Research Collaborative
Comprehensive Epilepsy Center
Department of Neurology
NYU Langone Grossman School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Sudden Unexplained death in childhood (SUDC) is the unexplained death of a child on or after their 1st birthday that remains unexplained after a comprehensive death investigation. About 400 SUDC occur annually between the ages of 1-18, but more than half occur in toddlers, aged 1-4 years. Since most deaths are sleep related and unwitnessed with unremarkable autopsies, mechanisms of deaths have eluded our understanding.
Febrile seizures are common in young children; ~ 3% of US children 6 months to 5 years will experience one. SUDC however has been associated with a 10-fold increase in febrile seizures; our study is the first to implicate them at time of death. The SUDC Registry and Research Collaborative (www.sudcrrc.org) at NYU Langone Health has enrolled over 300 cases of unexplained child death; seven with audiovisual recordings from the child’s bedroom during their last sleep period. More than 80% of the cases enrolled in the registry were children 1-4 years at the time of death. The seven cases with videos were aged 13-27 months with normal development and no pathogenic disease-causing variants by whole exome sequencing.
Dr. Zhang[/caption]
Jianzhi "George" Zhang
Dr. Klompas[/caption]
Michael Klompas MD, MPH, FIDSA, FSHEA
Hospital Epidemiologist
Brigham and Women’s Hospital
Professor of Medicine and Population Medicine
Harvard Medical School and
Harvard Pilgrim Health Care Institute
MedicalResearch.com: What is the background for this study? Can teeth be safely brush in patients who are comatose, intubated or have NG tubes?
Response: Pneumonia is thought to occur when secretions from the mouth get into the lungs. Since there are many microbes in the mouth, there’s a risk that secretions from the mouth that get into the lungs will lead to pneumonia. Toothbrushing may lower this risk by decreasing the quantity of microbes in the mouth.
It is indeed safe and appropriate to brush the teeth of someone who is comatose, intubated, or who has an NG tube. Indeed, our study found that the benefits of toothbrushing were clearest for patients receiving mechanical ventilation.
Dr. Angélica Cifuentes Kottkamp[/caption]
Angélica Cifuentes Kottkamp, MD
Assistant Professor of Medicine
NYU Grossman School of Medicine
Associate Program Director
Infectious Diseases & Immunology Fellowship
Associate Director for Research & Diversity
NYU Langone Vaccine Center & VTEU
Attending Physician
H+H Bellevue Virology Clinic
Division of Infectious Diseases & Immunology
NYU Grossman School of Medicine
MedicalResearch.com: What is the background for this study? How does the JYNNEOS vaccine differ from the smallpox vaccine?
Response: JYNNEOS vaccine is a smallpox vaccine that was repurposed for Mpox given the similarities between the two viruses (smallpox and mpox). The vaccine (JYNNEOS) had been studied in people without HIV therefore there was a gap in knowledge in how this vaccine, especially the small dose (intradermal dose), would work in patients with HIV.
These patients resulted to be the most affected by the mpox outbreak suffering the worse outcomes of the disease with the highest death rates.
Prof. Nathan Berger[/caption]
Nathan A. Berger, M.D.
Distinguished University Professor
Prof. Rong Xu[/caption]
Rong Xu, PhD
Professor, Biomedical Informatics
Director, Center for Artificial Intelligence in Drug Discovery
Case Western Reserve University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: 75% of the US Population has overweight or obesity and 15% has Type 2 Diabetes.
Both overweight/obesity and diabetes promote increased incidence and worse prognosis of colorectal cancer.
The new GLP1RA drug class are rapidly becoming the most effective treatment for both diabetes and overweight/obesity.
By controlling diabetes and overweight/obesity, we hypothesized that the GLP1RAs might be effective at reducing incidence of colorectal cancer.
Dr. Davaasambuu[/caption]
Dr Ganmaa Davaasambuu MD PhD
Associate Professor
Harvard T.H. Chan School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The crucial role of vitamin D in facilitating calcium absorption from the diet and promoting calcium deposition in bones (known as 'mineralization') has been a long-established understanding. Furthermore, some observational studies have reported an association between low vitamin D levels and a heightened risk of bone fractures in children. This raised the possibility that vitamin D supplements could potentially play a role in decreasing fracture risk in children with initially low baseline levels. However, clinical trials assessing the causal link between low vitamin D status and reduced fracture risk were necessary, and such trials had not been conducted before.
Dr. Traverso[/caption]
Giovanni Traverso MD PhD
Karl Van Tassel (1925) Career Development Professor
Department of Mechanical Engineering
Koch Institute of Integrative Cancer Research
Division of Gastroenterology
Brigham and Women’s Hospital
Harvard Medical School, Boston, MA, USA
MedicalResearch.com: What is the background for this study?
Response: I think its always important to acknowledge that this is a big team effort. We have the teams from MIT, Celero Systems, West Virgnia University (WVU) and Brigham and Women’s Hospital (BWH) all working together on this. For this study, Celero prototyped the devices that we tested in pre-clinical (Swine) models and in a first-in-human study with the team at WVU.
Our lab focuses on the development of ingestible devices for drug delivery and sensing and these have informed the development of these efforts as you can see.
MedicalResearch.com: What types of vital signs are measurable in this fashion?
Response: Heart rate and respiratory rate.
Dr. Schuler[/caption]
Charles Schuler, MD
Assistant Professor
Allergy and Clinical Immunology &
Mary H. Weiser Food Allergy Center
University of Michigan
MedicalResearch.com: What is the background for this study?
Response: Anaphylaxis is a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing, and shock. Food anaphylaxis sends 200,000 people to the emergency room annually in the United States. Oral food challenges are when a patient ingests increasing doses up to a full serving of the suspected food allergen under supervision of a medical provider, usually an allergist. These oral food challenges are the diagnostic standard for food allergy/anaphylaxis as skin and blood allergy tests have high false positive rates. Although a highly accurate test, patients often experience anaphylaxis during oral food challenges necessitating an epinephrine injection.
Prof. Durazzo[/caption]
Timothy C. Durazzo, PhD
Clinical Neuropsychologist and Research Scientist
Mental Illness Research and Education Clinical Centers
VA Palo Alto Health Care System
Professor, Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
MedicalResearch.com: What is the background for this study?
-There are a limited number of studies investigating changes in human brain structure, in individuals with an alcohol use disorder, with longer term abstinence after treatment.
-Our study was the first to assess for change in cortical thickness over approximately 7 months of abstinence in those seeking treatment of alcohol use disorder.
-Cortical thickness in humans is genetically and phenotypically distinct from other brain structural measures such as cortical volume and surface area.
-Therefore, assessment of changes in cortical thickness with longer-term abstinence provides additional information on how human brain structure recovers with sobriety.
Dr. Belloy[/caption]
Michael E. Belloy, PhD
Department of Neurology and Neurological Sciences
Stanford University, Stanford, California
MedicalResearch.com: What is the background for this study?
Response: Apolipoprotein E (APOE)*2 and APOE*4 are, respectively, the strongest protective and risk-increasing, genetic variants for late-onset Alzheimer disease. As such, one’s APOE genotype is highly relevant towards clinical trial design and Alzheimer’s disease research. However, most insights so far are focused on the associations of these APOE genotypes with Alzheimer’s disease risk in non-Hispanic white individuals.
One important aspect of our work is that we really increased sample sizes for non-Hispanic Black, Hispanic, and East Asian individuals, so that we now have better understanding of the associations of APOE genotypes with Alzheimer’s disease risk in these groups. In complement, we also did the largest investigation to date on the role of ancestry on the associations of APOE genotypes with Alzheimer’s disease risk. The scale of our study was thus a critical factor in generating novel insights.
Dr. Hosseini-Kamkar[/caption]
Niki Hosseini-Kamkar PhD
Postdoc, McGill University
MedicalResearch.com: What is the background for this study?
Response: Our primary question was: Do adults with a history of childhood trauma have altered
brain responses to psychological challenges? Previous evidence indicated that this can
occur in laboratory animals, but it has been unclear whether it occurs in humans.
Dr. Han[/caption]
Summer S Han, PhD
Associate Professor
Quantitative Sciences Unit
Stanford Center for Biomedical Informatics Research (BMIR)
Department of Neurosurgery and Department of Medicine
Department of Epidemiology & Population Health (by Courtesy)
Stanford University School of Medicine
[caption id="attachment_60981" align="alignleft" width="150"]
Dr. Choi[/caption]
Dr. Eunji Choi PhD
Instructor, Neurosurgery
Department: Adult Neurosurgery
Stanford University School of Medicine
MedicalResearch.com: What is the background for this study?